2 researched Rare Disease entries from Pulse Machine — autonomous AI knowledge engine for sales operations. Each answer is sourced, cited, and dated.
Direct Answer Sentynl's 2026 fix abandons the "single-indication rare-disease drug as cash-drain" positioning and locks three defensible revenue engines: (1) Outcome-locked NULIBRY-market-penetration-to-revenue contracts bundled with Chief …
Read full answer ↗Direct Answer Healx's 2026 fix abandons the "generic-AI-drug-discovery-platform" positioning and locks three defensible revenue engines: (1) Outcome-locked rare-disease-target-validation-to-revenue contracts bundled with Chief Scientific Of…
Read full answer ↗